Key result
Continuous ECG monitoring via implantable loop recorder in hemodialysis patients demonstrated a 20% rate of sudden cardiac death or arrhythmia device implantation.
Population
30 established hemodialysis patients, aged 68±12 years, 60% male, receiving hemodialysis for 45±40 months…
Design
Cohort
Follow-up
mean 12,648±9,024 hours/patient
Authors
Loading...
Suggests high arrhythmia burden in hemodialysis; hypothesis-generating and requires RCTs before changing practice.
Cohort (n=30)
No
Long-term continuous ECG monitoring in hemodialysis patients revealed a high incidence of significant arrhythmias, particularly bradyarrhythmias requiring pacemaker implantation.
Roberts et al. (2017) conducted a cohort in Hemodialysis (n=30). Implantable loop recorder (Reveal XT) was evaluated on Sudden cardiac death (SCD) or implantation of a (tachy or bradyarrhythmia controlling) device. Continuous ECG monitoring via implantable loop recorder in hemodialysis patients demonstrated a 20% rate of sudden cardiac death or arrhythmia device implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: